IPNA consensus definitions for clinical trial outcomes in steroid-resistant nephrotic syndrome
Pankaj Hari(Indian Council of Medical Research), Franz Schaefer(Heidelberg University), Hesham Safouh(Cairo University), Martin Christian, William E. Smoyer(Nationwide Children's Hospital), Kazumoto Iijima, Rajendra Bhimma(University of KwaZulu-Natal), Marina Vivarelli(Bambino Gesù Children's Hospital), Ali Düzova(Hacettepe University), Olivia Boyer(Hôpital Necker-Enfants Malades), Arvind Bagga(All India Institute of Medical Sciences), Susan Samuels(University of Calgary), Priyanka Khandelwal(Chacha Nehru Bal Chikitsalaya), Francesco Cano(Hospital Luis Calvo Mackenna), Hee Gyung Kang(Seoul National University Children's Hospital)
Cited by 1
Related Papers
Non-Transgenic Mouse Models of Kidney Disease
|The Nephron journals/Nephron journals|2016|1.9k
Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis
|Nature Medicine|2011|834
Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference
|Kidney International|2020|708
Management of Childhood Onset Nephrotic Syndrome
|PEDIATRICS|2009|312
Clinical Features of Anti-Factor H Autoantibody–Associated Hemolytic Uremic Syndrome
|Journal of the American Society of Nephrology|2010|296